Search results for "FDA update"
New safety labels added to entire class of fluoroquinolones
Oral and injectable fluoroquinolones are associated with side effects involving tendons, muscles, joints, nerves, and the central nervous system, an FDA safety review found. These side effects may occur hours to weeks after use and can be permanent.
https://immattersacp.org/weekly/archives/2016/08/02/5.htm
2 Aug 2016
Warning on medication confusion, recalls due to sterility
This update covers possible confusion between an antidepressant and an anti-clotting drug, as well as 2 sterility warnings.
https://immattersacp.org/archives/2015/10/fda.htm
1 Oct 2015
New cardiovascular indication approved for diabetes drug
This column reviews details on recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2022/04/new-cardiovascular-indication-approved-for-diabetes-drug.htm
1 Apr 2022
New safety notice issued for alosetron hydrochloride (Lotronex)
Clinicians are advised to evaluate patients with signs of ischemic colitis (e.g., rectal bleeding, bloody diarrhea, new or worsening abdominal pain), discontinue the drug immediately if signs of ischemic colitis occur, and counsel patients to discontinue the drug immediately if they develop constipation or symptoms of ischemic colitis.
https://immattersacp.org/weekly/archives/2016/06/14/6.htm
14 Jun 2016
New category of OTC hearing aids; FMT and monkeypox
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2022/10/new-category-of-otc-hearing-aids-fmt-and-monkeypox.htm
1 Oct 2022
Approvals for an oral anticoagulant, generic esomeprazole
This update covers the approval of an oral medication to reduce the risk of stroke and embolism in atrial fibrillation and the first generic version of esomeprazole.
https://immattersacp.org/archives/2015/04/fda.htm
1 Apr 2015
Weight-loss drug and at-home HIV test approved
This regulatory update covers approval of lorcaserin HCl for chronic weight management, as well as a new at-home mouth swab test for HIV 1 and 2.
https://immattersacp.org/archives/2012/09/fda.htm
1 Sep 2012
Latest updates on ACP's priorities, initiatives
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, ACP Internist Weekly.
https://immattersacp.org/archives/2022/03/latest-updates-on-acps-priorities-initiatives.htm
1 Mar 2022
Warning on diabetes drugs, approval of adjuvant flu vaccine
This update covers a warning on sodium-glucose cotransporter-2 inhibitors and approval of a trivalent vaccine for the prevention of seasonal influenza in people age 65 years and older.
https://immattersacp.org/archives/2016/02/fda.htm
1 Feb 2016
Warning on NSAIDs; new schizophrenia drug approved
This update covers a strengthened warning on NSAIDs and a new drug to treat schizophrenia.
https://immattersacp.org/archives/2015/09/fda.htm
1 Sep 2015